论文信息 - Chimeric antigen receptor (CAR+) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC). - 字舞流文

Chimeric antigen receptor (CAR+) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC).

H. Scher | Jason S. Lewis | M. Sadelain | H. Schöder | Melanie A Hullings | P. Zanzonico | I. Rivière | Xiuyan Wang | G. Arauz | S. Bartido | Jason S. Lewis | Melanie A. Hullings | Gabrielle Arauz